๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Chromosome abnormalities in dyskeratosis congenita

โœ Scribed by Scappaticci, Susi ;Fraccaro, Marco ;Cerimele, Decio


Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
149 KB
Volume
34
Category
Article
ISSN
0148-7299

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Etiologic heterogeneity in dyskeratosis
โœ Pai, G. Shashidhar ;Morgan, Samuel ;Whetsell, Carl ;Opitz, John M. ;Reynolds, Ja ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 354 KB ๐Ÿ‘ 1 views
Chromosome abnormalities in erythroleuke
โœ Judith Stamberg ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 432 KB ๐Ÿ‘ 1 views

Erythroleukemia (EL) is a heterogeneous disease in terms of cell type affected, chromosome abnormalities found in the malignant clone, and clinical course. In this article, cases of erythroid EL from the recent medical literature are reviewed using cytogenetic criteria to distinguish such cases from

Chromosome abnormality in Kallmann syndr
โœ Best, Lyle G. ;Wasdahl, Walter A. ;Larson, Linda M. ;Sturlaugson, Jean ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 414 KB ๐Ÿ‘ 1 views
Chromosome abnormalities in ovarian aden
โœ Raymond Taetle; Mikel Aickin; Jin-Ming Yang; Lita Panda; Julia Emerson; Denise R ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 428 KB

Cytogenetics provides important insights into the molecular pathogenesis of human cancers. Although extensive data exist on recurring cytogenetic abnormalities in hematologic cancers, data on individual solid tumor types remain limited. Previous studies of ovarian carcinoma indicated the presence of

Chromosome abnormalities in congenital h
โœ Johnson, Mark C.; Hing, Anne; Wood, Mary K.; Watson, Michael S. ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 146 KB ๐Ÿ‘ 1 views

Refinements in cytogenetic techniques have promoted progress in understanding the role that chromosome abnormalities play in the cause of congenital heart disease. To determine if mutations at specific loci cause congenital heart disease, irrespective of the presence of other defects, and to estimat